Phenotype, penetrance, and treatment of 133 cytotoxic T‐lymphocyte antigen 4–insufficient subjects
暂无分享,去创建一个
O. Elemento | T. Giese | A. Schulz | V. Kanderova | V. Lougaris | A. Plebani | R. Geha | J. Chou | H. Kanegane | T. Chatila | C. Cunningham-Rundles | K. Sullivan | E. Froňková | A. Šedivá | J. Litzman | S. Ehl | A. Franke | S. Snapper | I. Dybedal | S. Zeissig | M. Takagi | H. Lorenz | K. Taskén | M. Moutschen | A. Schmitt-Graeff | C. Klemann | N. Frede | A. Bulashevska | M. Seidl | K. Warnatz | B. Grimbacher | A. Hoshino | F. Hauck | S. Okada | Masao Kobayashi | K. Imai | A. Kolios | S. Seneviratne | Z. Šumník | R. Blumberg | M. Recher | M. Kanariou | F. L. van de Veerdonk | T. Niehues | D. Sansom | P. Arkwright | L. Alsina | U. Salzer | C. Speckmann | J. P. Schmid | E. McDermott | M. Slatter | D. Wolff | A. Cant | T. Freiberger | L. Petruželková | G. Dückers | M. Albert | L. Giulino-Roth | Z. Kucuk | O. Neth | S. Hambleton | S. Hayakawa | F. Emmerich | A. Leichtner | H. Chapdelaine | C. Schwab | Annemarie Gabrysch | P. Olbrich | V. Patiño | J. Haddock | J. Lucena | V. Reiser | D. Schubert | C. Price | G. Unglik | Craig D. Platt | S. Bunn | M. Kurzai | F. Casals | A. Deyà-Martínez | A. Deyá-Martinez | E. Mcdermott | À. Deyà-Martínez | C. Platt | L. Giulino‐Roth | Seiichi Hayakawa
[1] Q. Pan-Hammarström,et al. Study of an extended family with CTLA-4 deficiency suggests a CD28/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity. , 2018, Clinical immunology.
[2] T. Chatila,et al. CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder. , 2017, The Journal of allergy and clinical immunology.
[3] A. Worth,et al. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. , 2017, Blood.
[4] M. Mehling,et al. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. , 2017, The Journal of allergy and clinical immunology.
[5] T. Torgerson,et al. Hematopoietic stem cell transplantation for CTLA4 deficiency. , 2016, The Journal of allergy and clinical immunology.
[6] F. Rieux-Laucat,et al. LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis. , 2016, Clinical immunology.
[7] J. Henter,et al. Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation , 2016, Journal of Clinical Immunology.
[8] B. Grimbacher,et al. Infancy-Onset T1DM, Short Stature, and Severe Immunodysregulation in Two Siblings With a Homozygous LRBA Mutation. , 2016, The Journal of clinical endocrinology and metabolism.
[9] T. Morio,et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. , 2016, The Journal of allergy and clinical immunology.
[10] M. Corr. Faculty Opinions recommendation of AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. , 2015 .
[11] J. Hughes,et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy , 2015, Science.
[12] A. Borkhardt,et al. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. , 2015, Clinical immunology.
[13] A. Deutschmann,et al. Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency , 2015, The Journal of allergy and clinical immunology.
[14] Elisha D O Roberson,et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. , 2015, Blood.
[15] B. Grimbacher,et al. Atypical Manifestation of LRBA Deficiency with Predominant IBD-like Phenotype , 2015, Inflammatory bowel diseases.
[16] Toshiro K. Ohsumi,et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. , 2015, The Journal of allergy and clinical immunology.
[17] R. Geha,et al. Spectrum of Phenotypes Associated with Mutations in LRBA , 2015, Journal of Clinical Immunology.
[18] V. Hwa,et al. A Successful HSCT in a Girl with Novel LRBA Mutation with Refractory Celiac Disease , 2015, Journal of Clinical Immunology.
[19] O. Ohara,et al. A Patient with CTLA-4 Haploinsufficiency Presenting Gastric Cancer , 2015, Journal of Clinical Immunology.
[20] A. Franke,et al. Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4 , 2014, Gut.
[21] A. Schäffer,et al. Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations , 2014, Nature Medicine.
[22] J. B. Oliveira,et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 , 2014, Science.
[23] J. Kere,et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease , 2014, Nature Genetics.
[24] J. Casanova,et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2015, Journal of Clinical Immunology.
[25] L. Walker. Treg and CTLA-4: Two intertwining pathways to immune tolerance , 2013, Journal of autoimmunity.
[26] S. Nejentsev,et al. LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. , 2012, The Journal of allergy and clinical immunology.
[27] R. Geha,et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. , 2012, The Journal of allergy and clinical immunology.
[28] R. Bacchetta,et al. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..
[29] Bodo Grimbacher,et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. , 2012, American Journal of Human Genetics.
[30] L. Walker,et al. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses , 2011, Nature Reviews Immunology.
[31] G. Anderson,et al. Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 , 2011, Science.
[32] Steven M. Holland,et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2009, Front. Immun..
[33] J. B. Oliveira,et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. , 2010, Blood.
[34] J. Bluestone,et al. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells , 2009, Immunological reviews.
[35] R. Friedline,et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance , 2009, The Journal of experimental medicine.
[36] T. Nomura,et al. CTLA-4 Control over Foxp3+ Regulatory T Cell Function , 2008, Science.
[37] Hans D. Ochs,et al. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity , 2007, Immunologic research.
[38] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[39] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[40] Andrea Iaboni,et al. The interaction properties of costimulatory molecules revisited. , 2002, Immunity.
[41] A. Fedorov,et al. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.
[42] T. Mak,et al. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.
[43] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.